# Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions

> **NCT00865618** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 60 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Eplerenone 50 mg Tablets Sandoz Inc., USA
- **DRUG:** Inspra 50 mg Tablets GD Searle LLC, USA

## Key facts

- **NCT ID:** NCT00865618
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865618, "Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00865618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*